AB Science's new Phase 3 trial of masitinib for ALS has been cleared to launch in certain European countries, as well as in ...

Columnist Kristin Neva shares what she feels has worked and not worked in terms of slowing her husband's ALS progression over 15 years.

The FDA approved an expanded access program for troculeucel, making the treatment available to patients outside clinical trials.

The ongoing EAP that is providing ALS patients with access to MN-166 (ibudilast) outside of a clinical trial is adding more ...

Caregivers can keep communication going for people living with ALS by using tools, patience, and clear language.

The ALS Association has announced the eight winners two new Hoffman award programs designed to improve access to multidisciplinary ALS care.